Efficacy and implications of minimum retesting intervals for HbA1c

Abstract

Get full access to this article

View all access options for this article.

References

National Institute for Health and Care Excellence (NICE) . Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline [CG87] 2012. Available at: https://www.nice.org.uk/guidance/cg87 (Accessed 21 February 2025).

National Institute for Health and Care Excellence (NICE)

Type 2 diabetes in adults: management. NICE guideline [NG28] 2022. Available at: https://www.nice.org.uk/guidance/ng28 (Accessed: 21 February 2025).

Royal College of Pathologists (RCPath) . National minimum retesting intervals in pathology 2021. Available at: https://www.rcpath.org/static/253e8950-3721-4aa2-8ddd4bd94f73040e/g147_national-minimum_retesting_intervals_in_pathology.pdf. (Accessed 21 February 2025).

Fryer

Smellie

WSA

. Managing demand for laboratory tests: a laboratory toolkit. J Clin Pathol 2013; 66(1): 62–72, Available at: https://doi.org/10.1136/jclinpath-2011-200524 (Accessed: 25 February 2025).